These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 20582308

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A small molecule fusion inhibitor of dengue virus.
    Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W.
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [Abstract] [Full Text] [Related]

  • 26. Release of dengue virus genome induced by a peptide inhibitor.
    Lok SM, Costin JM, Hrobowski YM, Hoffmann AR, Rowe DK, Kukkaro P, Holdaway H, Chipman P, Fontaine KA, Holbrook MR, Garry RF, Kostyuchenko V, Wimley WC, Isern S, Rossmann MG, Michael SF.
    PLoS One; 2012 Dec; 7(11):e50995. PubMed ID: 23226444
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections.
    Ajmal A, Shahab M, Waqas M, Zheng G, Zulfat M, Bin Jardan YA, Wondmie GF, Bourhia M, Ali I.
    Sci Rep; 2024 Jun 07; 14(1):13130. PubMed ID: 38849372
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding.
    Watterson D, Kobe B, Young PR.
    J Gen Virol; 2012 Jan 07; 93(Pt 1):72-82. PubMed ID: 21957126
    [Abstract] [Full Text] [Related]

  • 31. Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.
    Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.
    J Biol Chem; 2009 Mar 06; 284(10):6575-84. PubMed ID: 19114713
    [Abstract] [Full Text] [Related]

  • 32. Antiviral activity of silymarin and baicalein against dengue virus.
    Low ZX, OuYong BM, Hassandarvish P, Poh CL, Ramanathan B.
    Sci Rep; 2021 Oct 27; 11(1):21221. PubMed ID: 34707245
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. PD1 CD44 antiviral peptide as an inhibitor of the protein-protein interaction in dengue virus invasion.
    Recalde-Reyes DP, Rodríguez-Salazar CA, Castaño-Osorio JC, Giraldo MI.
    Peptides; 2022 Jul 27; 153():170797. PubMed ID: 35378215
    [Abstract] [Full Text] [Related]

  • 36. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
    Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS.
    Proc Natl Acad Sci U S A; 2014 Feb 04; 111(5):1939-44. PubMed ID: 24385585
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR.
    Antiviral Res; 2009 Dec 04; 84(3):234-41. PubMed ID: 19781577
    [Abstract] [Full Text] [Related]

  • 39. Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus.
    Song KY, Zhao H, Li SH, Li XF, Deng YQ, Wang HJ, Ye Q, Zhu SY, Jiang ZY, Zhang FC, Qin ED, Qin CF.
    J Gen Virol; 2013 Jul 04; 94(Pt 7):1510-1516. PubMed ID: 23559476
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.